世界のグリコーゲン代謝＆糖原病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5757
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、グリコーゲン代謝＆糖原病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・グリコーゲン代謝＆糖原病治療の市場動向
・企業の競争状況、市場シェア
・グリコーゲン代謝＆糖原病治療の種類別市場規模と予測2016-2027（OTC、Rx薬剤）
・グリコーゲン代謝＆糖原病治療の用途別市場規模と予測2016-2027（病院、小売薬局）
・グリコーゲン代謝＆糖原病治療の北米市場規模2016-2027（アメリカ、カナダ）
・グリコーゲン代謝＆糖原病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・グリコーゲン代謝＆糖原病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・グリコーゲン代謝＆糖原病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・グリコーゲン代謝＆糖原病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck、Novartis、Takeda Pharmaceutical、Astra Zeneca、Beohrigher Ingelheim、KOWA、Kythera、Fuji yakuhin、LG Chem、Mitsubishi Chemical）
・結論

Market Analysis and Insights: Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market
The global Glycogen Metabolism and Glycogen Storage Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glycogen Metabolism and Glycogen Storage Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glycogen Metabolism and Glycogen Storage Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glycogen Metabolism and Glycogen Storage Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glycogen Metabolism and Glycogen Storage Disease Treatment market.

Global Glycogen Metabolism and Glycogen Storage Disease Treatment Scope and Market Size
Glycogen Metabolism and Glycogen Storage Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glycogen Metabolism and Glycogen Storage Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
OTC
Rx Drugs

Segment by Application
Hospital
Retail Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Beohrigher Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Chem
Mitsubishi Chemical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Perspective (2016-2027)
2.2 Glycogen Metabolism and Glycogen Storage Disease Treatment Growth Trends by Regions
2.2.1 Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glycogen Metabolism and Glycogen Storage Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Glycogen Metabolism and Glycogen Storage Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Glycogen Metabolism and Glycogen Storage Disease Treatment Industry Dynamic
2.3.1 Glycogen Metabolism and Glycogen Storage Disease Treatment Market Trends
2.3.2 Glycogen Metabolism and Glycogen Storage Disease Treatment Market Drivers
2.3.3 Glycogen Metabolism and Glycogen Storage Disease Treatment Market Challenges
2.3.4 Glycogen Metabolism and Glycogen Storage Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glycogen Metabolism and Glycogen Storage Disease Treatment Players by Revenue
3.1.1 Global Top Glycogen Metabolism and Glycogen Storage Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue
3.4 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Concentration Ratio
3.4.1 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue in 2020
3.5 Glycogen Metabolism and Glycogen Storage Disease Treatment Key Players Head office and Area Served
3.6 Key Players Glycogen Metabolism and Glycogen Storage Disease Treatment Product Solution and Service
3.7 Date of Enter into Glycogen Metabolism and Glycogen Storage Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glycogen Metabolism and Glycogen Storage Disease Treatment Breakdown Data by Type
4.1 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Glycogen Metabolism and Glycogen Storage Disease Treatment Breakdown Data by Application
5.1 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Glycogen Metabolism and Glycogen Storage Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size (2016-2027)
6.2 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type
6.2.1 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2027)
6.3 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application
6.3.1 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2027)
6.4 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country
6.4.1 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size (2016-2027)
7.2 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type
7.2.1 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application
7.3.1 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country
7.4.1 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size (2016-2027)
9.2 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type
9.2.1 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application
9.3.1 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country
9.4.1 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.1.4 Merck Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.2.4 Novartis Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.3.4 Takeda Pharmaceutical Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Astra Zeneca Business Overview
11.4.3 Astra Zeneca Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.4.4 Astra Zeneca Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.4.5 Astra Zeneca Recent Development
11.5 Beohrigher Ingelheim
11.5.1 Beohrigher Ingelheim Company Details
11.5.2 Beohrigher Ingelheim Business Overview
11.5.3 Beohrigher Ingelheim Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.5.4 Beohrigher Ingelheim Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.5.5 Beohrigher Ingelheim Recent Development
11.6 KOWA
11.6.1 KOWA Company Details
11.6.2 KOWA Business Overview
11.6.3 KOWA Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.6.4 KOWA Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.6.5 KOWA Recent Development
11.7 Kythera
11.7.1 Kythera Company Details
11.7.2 Kythera Business Overview
11.7.3 Kythera Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.7.4 Kythera Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.7.5 Kythera Recent Development
11.8 Fuji yakuhin
11.8.1 Fuji yakuhin Company Details
11.8.2 Fuji yakuhin Business Overview
11.8.3 Fuji yakuhin Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.8.4 Fuji yakuhin Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.8.5 Fuji yakuhin Recent Development
11.9 LG Chem
11.9.1 LG Chem Company Details
11.9.2 LG Chem Business Overview
11.9.3 LG Chem Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.9.4 LG Chem Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.9.5 LG Chem Recent Development
11.10 Mitsubishi Chemical
11.10.1 Mitsubishi Chemical Company Details
11.10.2 Mitsubishi Chemical Business Overview
11.10.3 Mitsubishi Chemical Glycogen Metabolism and Glycogen Storage Disease Treatment Introduction
11.10.4 Mitsubishi Chemical Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
11.10.5 Mitsubishi Chemical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Regions (2022-2027)
Table 10. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Trends
Table 11. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Drivers
Table 12. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Challenges
Table 13. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Restraints
Table 14. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top Glycogen Metabolism and Glycogen Storage Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment as of 2020)
Table 17. Ranking of Global Top Glycogen Metabolism and Glycogen Storage Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Glycogen Metabolism and Glycogen Storage Disease Treatment Product Solution and Service
Table 21. Date of Enter into Glycogen Metabolism and Glycogen Storage Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Glycogen Metabolism and Glycogen Storage Disease Treatment Product
Table 64. Merck Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Glycogen Metabolism and Glycogen Storage Disease Treatment Product
Table 69. Novartis Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Takeda Pharmaceutical Company Details
Table 72. Takeda Pharmaceutical Business Overview
Table 73. Takeda Pharmaceutical Glycogen Metabolism and Glycogen Storage Disease Treatment Product
Table 74. Takeda Pharmaceutical Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. Takeda Pharmaceutical Recent Development
Table 76. Astra Zeneca Company Details
Table 77. Astra Zeneca Business Overview
Table 78. Astra Zeneca Glycogen Metabolism and Glycogen Storage Disease Treatment Product
Table 79. Astra Zeneca Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. Astra Zeneca Recent Development
Table 81. Beohrigher Ingelheim Company Details
Table 82. Beohrigher Ingelheim Business Overview
Table 83. Beohrigher Ingelheim Glycogen Metabolism and Glycogen Storage Disease Treatment Product
Table 84. Beohrigher Ingelheim Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. Beohrigher Ingelheim Recent Development
Table 86. KOWA Company Details
Table 87. KOWA Business Overview
Table 88. KOWA Glycogen Metabolism and Glycogen Storage Disease Treatment Product
Table 89. KOWA Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 90. KOWA Recent Development
Table 91. Kythera Company Details
Table 92. Kythera Business Overview
Table 93. Kythera Glycogen Metabolism and Glycogen Storage Disease Treatment Product
Table 94. Kythera Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 95. Kythera Recent Development
Table 96. Fuji yakuhin Company Details
Table 97. Fuji yakuhin Business Overview
Table 98. Fuji yakuhin Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 99. Fuji yakuhin Recent Development
Table 100. LG Chem Company Details
Table 101. LG Chem Business Overview
Table 102. LG Chem Glycogen Metabolism and Glycogen Storage Disease Treatment Product
Table 103. LG Chem Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 104. LG Chem Recent Development
Table 105. Mitsubishi Chemical Company Details
Table 106. Mitsubishi Chemical Business Overview
Table 107. Mitsubishi Chemical Glycogen Metabolism and Glycogen Storage Disease Treatment Product
Table 108. Mitsubishi Chemical Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 109. Mitsubishi Chemical Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Glycogen Metabolism and Glycogen Storage Disease Treatment Report Years Considered
Figure 8. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Regions (2022-2027)
Figure 12. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Players in 2020
Figure 13. Global Top Glycogen Metabolism and Glycogen Storage Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycogen Metabolism and Glycogen Storage Disease Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue in 2020
Figure 15. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Type (2016-2027)
Figure 19. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Application (2016-2027)
Figure 20. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Country (2016-2027)
Figure 21. United States Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Type (2016-2027)
Figure 25. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Application (2016-2027)
Figure 26. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Country (2016-2027)
Figure 27. Germany Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Region (2016-2027)
Figure 37. China Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Merck Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 57. Novartis Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 58. Takeda Pharmaceutical Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 59. Astra Zeneca Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 60. Beohrigher Ingelheim Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 61. KOWA Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 62. Kythera Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 63. Fuji yakuhin Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 64. LG Chem Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 65. Mitsubishi Chemical Revenue Growth Rate in Glycogen Metabolism and Glycogen Storage Disease Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界のリソソーム蓄積症治療市場規模・現状・予測（2021年-2027年）

Global Lysosomal Storage Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4451 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、リソソーム蓄積症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、幹細胞移植、基質減少療法、その他）、用途別市場規模（病院、クリニック、幹細胞移植センター、研究機関、その他）、主要地域...

世界の糖原病（GSD）臨床試験市場規模・現状・予測（2021年-2027年）

Global Glycogen Storage Disorders (GSD) Clinical Trials Market Size, Status and Forecast 2021-2027
QFJ1-4266 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、糖原病（GSD）臨床試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界のバッテン病治療市場規模・現状・予測（2021年-2027年）

Global Batten Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3891 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（作業療法、理学療法）、用途別市場規模（乳児NCL、後期乳児NCL、少年NCL、成人NCL）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のタバコ代謝遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Cigarette Metabolism Gene Testing Market Size, Status and Forecast 2021-2027
QFJ1-4020 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、タバコ代謝遺伝子検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝学的検査、遺伝子発現検査、診断用検査、生殖発生学的検査）、用途別市場規模（病院、診療所、診断センター）、主要地域別市場規模（北米...

世界のアジソン病用治療市場規模・現状・予測（2021年-2027年）

Global Addison's Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3763 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、アジソン病用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口コルチコステロイド、コルチコステロイド注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界のアルコール代謝遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Alcohol Metabolism Genetic Testing Market Size, Status and Forecast 2021-2027
QFJ1-3775 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、アルコール代謝遺伝子検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査）、用途別市場規模（病院、診療所、診断センター）、主要地域別市場...

世界のICAD (頭蓋内アテローム性動脈硬化症) 病理学治療市場規模・現状・予測（2021年-2027年）

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5203 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステント、PTAバルーン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメ...

世界の糖原病（GSD）臨床試験市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glycogen Storage Disorders (GSD) Clinical Trials Market The global Glycogen Storage Disorders (GSD) Clinical Trials market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard ac…
代謝作用薬品のグローバル市場2021 Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. USA is the largest supplier of Metabolism Drugs, with production revenue market share over 4…
グリコーゲン合成酵素キナーゼ3ベータのグローバル市場調査 2019年 The global Glycogen Synthase Kinase 3 Beta market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glycogen Synthase Kinase 3 Beta volume and value at global level, regional level and company level. From a …
世界のタバコ代謝遺伝子検査市場規模・現状・予測（2021年-2027年） A detection method for cigarette metabolism Market Analysis and Insights: Global Cigarette Metabolism Gene Testing Market The global Cigarette Metabolism Gene Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
世界のリソソーム蓄積症治療市場規模・現状・予測（2021年-2027年） Lysosomal storage disease (LTD) is caused by defect in lysosomal functions and degradation pathway. It is caused by progressive accumulation of metabolites. LTD is a rare inherited metabolic disorder. Market Analysis and Insights: Global Lysosomal Storage Disease Treatment Market The global Lysosoma…